Bausch Health Companies Inc reports results for the quarter ended March 31 - Earnings Summary

• Bausch Health Companies Inc BHC.TO reported quarterly adjusted earnings of 60 cents​​ per share for the quarter ended March 31, identical to the same quarter last year. The mean expectation of four analysts for the quarter was for earnings of 79 cents per share. Wall Street expected results to range from 72 cents to 92 cents per share.

• Revenue fell 99.9% to $2.26 million from a year ago; analysts expected $2.27 billion.

• Bausch Health Companies Inc's reported EPS for the quarter was a loss of 16 cents​.

• Bausch Health Companies Inc shares had fallen by 18.5% this quarter and lost 34.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.5% in the last three months.​

• In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "hold"

• Wall Street's median 12-month price target for Bausch Health Companies Inc is $8.50

This summary was machine generated from LSEG data May 1 at 12:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)